Bruce Horten

2.2k total citations · 1 hit paper
30 papers, 1.7k citations indexed

About

Bruce Horten is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Bruce Horten has authored 30 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Genetics. Recurrent topics in Bruce Horten's work include Glioma Diagnosis and Treatment (8 papers), Neuroblastoma Research and Treatments (6 papers) and Meningioma and schwannoma management (4 papers). Bruce Horten is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Neuroblastoma Research and Treatments (6 papers) and Meningioma and schwannoma management (4 papers). Bruce Horten collaborates with scholars based in United States, France and United Kingdom. Bruce Horten's co-authors include Marilyn A. Owens, Lucien J. Rubinstein, William R. Shapiro, H. Urich, Robert S. Porro, Jeffrey C. Allen, Richard W. Price, Gerald Rosen, Dusan Stefoski and George A. Basler and has published in prestigious journals such as Brain, Cancer and Cancer Research.

In The Last Decade

Bruce Horten

29 papers receiving 1.6k citations

Hit Papers

HER2 Amplification Ratios by Fluorescence In Situ Hybridi... 2004 2026 2011 2018 2004 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce Horten United States 16 673 412 398 395 341 30 1.7k
Bernard Mariamé France 24 916 1.4× 170 0.4× 700 1.8× 312 0.8× 198 0.6× 46 2.3k
R Rampling United Kingdom 23 810 1.2× 704 1.7× 778 2.0× 372 0.9× 355 1.0× 49 2.7k
Harald Stein Germany 33 1.5k 2.2× 672 1.6× 941 2.4× 224 0.6× 548 1.6× 53 4.0k
M. L. Hansmann Germany 20 816 1.2× 651 1.6× 280 0.7× 161 0.4× 240 0.7× 43 2.2k
Livia Lumbroso‐Le Rouic France 28 846 1.3× 207 0.5× 461 1.2× 417 1.1× 547 1.6× 119 2.5k
Steven C. Ziesmer United States 35 1.2k 1.8× 716 1.7× 580 1.5× 197 0.5× 189 0.6× 65 3.2k
Ingrid Simonitsch‐Klupp Austria 29 586 0.9× 376 0.9× 356 0.9× 263 0.7× 270 0.8× 93 2.4k
Konnie M. Hebeda Netherlands 27 883 1.3× 457 1.1× 524 1.3× 268 0.7× 132 0.4× 93 2.5k
Joost J. Oudejans Netherlands 34 1.3k 2.0× 342 0.8× 717 1.8× 275 0.7× 124 0.4× 68 3.0k
Milena Piccioli Italy 20 788 1.2× 370 0.9× 441 1.1× 162 0.4× 108 0.3× 40 2.1k

Countries citing papers authored by Bruce Horten

Since Specialization
Citations

This map shows the geographic impact of Bruce Horten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Horten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Horten more than expected).

Fields of papers citing papers by Bruce Horten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Horten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Horten. The network helps show where Bruce Horten may publish in the future.

Co-authorship network of co-authors of Bruce Horten

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Horten. A scholar is included among the top collaborators of Bruce Horten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Horten. Bruce Horten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anderson, Steven M., et al.. (2017). Abstract 663: Clinical performance and utilization of 3 PD-L1 immunohistochemical assays. Cancer Research. 77(13_Supplement). 663–663. 4 indexed citations
2.
Rouleau, Cécile, Diego A. Gianolio, Robert Smale, et al.. (2015). Anti-Endosialin Antibody–Drug Conjugate: Potential in Sarcoma and Other Malignancies. Molecular Cancer Therapeutics. 14(9). 2081–2089. 34 indexed citations
3.
Yang, Hai-Su & Bruce Horten. (2014). Gain of copy number and amplification of the RET gene in lung cancer. Experimental and Molecular Pathology. 97(3). 465–469. 10 indexed citations
4.
Rouleau, Cécile, Robert Smale, Diego A. Gianolio, et al.. (2009). Abstract C80: Characterizing models for personalized medicine: Endosialin in sarcoma from cultured cells to mice to humans. Molecular Cancer Therapeutics. 8(12_Supplement). C80–C80. 1 indexed citations
5.
Rouleau, Cécile, William Weber, Robert Smale, et al.. (2008). Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma. Clinical Cancer Research. 14(22). 7223–7236. 86 indexed citations
6.
Owens, Marilyn A., et al.. (2004). HER2 Amplification Ratios by Fluorescence In Situ Hybridization and Correlation with Immunohistochemistry in a Cohort of 6556 Breast Cancer Tissues. Clinical Breast Cancer. 5(1). 63–69. 510 indexed citations breakdown →
7.
Leo, Angelo Di, Mitch Dowsett, Bruce Horten, & Frédérique Penault‐Llorca. (2002). Current Status of HER2 Testing. Oncology. 63(Suppl. 1). 25–32. 38 indexed citations
8.
Hoffman, Ronald A. & Bruce Horten. (1989). Rheumatoid nodule of the temporal bone. The Journal of Laryngology & Otology. 103(8). 768–770. 4 indexed citations
9.
Rodman, John S., et al.. (1989). Urothelial Injury from Ethylenediaminetetraacetic Acid Used as an Irrigant in the Urinary Tract. The Journal of Urology. 142(5). 1359–1360. 12 indexed citations
10.
Miller, Donald R., Kirtesh R. Patel, Jeffrey C. Allen, & Bruce Horten. (1983). Neuroblastoma, tuberous sclerosis, and subependymal giant cell astrocytoma.. PubMed. 5(2). 213–8. 12 indexed citations
11.
Jereb, Berta, Narayan Sundaresan, Bruce Horten, Alison Reid, & Joseph H. Galicich. (1981). Supratentorial recurrences in medulloblastoma. Cancer. 47(4). 806–809. 45 indexed citations
12.
Horten, Bruce, et al.. (1981). Multifocal varicella‐zoster virus leukoencephalitis temporally remote from herpes zoster. Annals of Neurology. 9(3). 251–266. 72 indexed citations
13.
Krol, George & Bruce Horten. (1980). Primary neuroblastoma of the cauda equina.. PubMed. 10(4). 164–6. 1 indexed citations
14.
Allen, Jeffrey C., et al.. (1980). Leukoencephalopathy following high-dose iv methotrexate chemotherapy with leucovorin rescue.. PubMed. 64(12). 1261–73. 102 indexed citations
15.
Rottenberg, David A., Bruce Horten, Jae‐Ho Kim, & Jerome B. Posner. (1980). Progressive white matter destruction following irradiation of an extracranial neoplasm. Annals of Neurology. 8(1). 76–78. 11 indexed citations
16.
Yung, W. K. Alfred, Bruce Horten, & William R. Shapiro. (1979). Meningeal gliomatosis: a review of twelve cases.. PubMed. 104. 83–5. 1 indexed citations
17.
Horten, Bruce, et al.. (1977). The angioblastic meningioma: A reappraisal of a nosological problem. Journal of the Neurological Sciences. 31(3). 387–410. 78 indexed citations
18.
Horten, Bruce, et al.. (1976). In vitro characteristics of a sacrococcygeal chordoma maintained in tissue and organ culture systems. Acta Neuropathologica. 35(1). 13–25. 26 indexed citations
19.
Horten, Bruce, et al.. (1976). Human ecchordosis physaliphora and chick embryonic notochord. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 371(4). 295–303. 13 indexed citations
20.
Horten, Bruce & Lucien J. Rubinstein. (1976). PRIMARY CEREBRAL NEUROBLASTOMA. Brain. 99(4). 735–756. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026